Reference | Mothers’ age (years) | E 1) | Immune prophylaxis | Sample size | Newborn | 7-12 month infant | >12 month child | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Mother (schedule/pregnancy month) | Child (schedule/infant month) | HBsAg+ | HBsAb+ | HBsAg+ | HBsAb+ | HBsAg+ | HBsAb+ | ||||
Ji 2003 [30] | 21-31 | 1 | T: HBIG 200 IU (7,8,9) | NR | T:29 | T:3 | T:10 | NR | NR | NR | NR |
C: none | Â | C:31 | C:5 | C:3 | |||||||
Xu 2006 [31] | NR | 1 | T: HBIG 200 IU (7,8,9) | NR | T:30 | T:7 | NR | NR | NR | NR | NR |
Repeated [32] | C: none | C:30 | C:20 | ||||||||
Yuan 2006 [22] | 20-33 | 1 | T: HBIG 400 IU (7,8,9) | T : HBIG 200 IU(0) + RV 5 ug(0,1,6) | T:118 | T:27 | T:0 | T:13 | T:101 | NR | NR |
C: Diluent | C: HBIG 200 IU(0) + RV 5 ug(0,1,6) | C:113 | C:32 | C:0 | C:17 | C:112 | |||||
Chen 2007 [33] | NR | 1 | T1: HBIG 200 IU (7,8,9) | T1: HBIG 200 IU(0,0.5) + RV 5 ug(0,1,6) | T1:45 | T1: 1 | T1: 14 | T1: 1 | T1:33 | NR | NR |
T2: None | T2: HBIG 200 IU(0,0.5) + RV 5 ug(0,1,6) | T2:44 | T2: No | T2: No | T2: 3 | T2: 35 | |||||
C:None | C: RV 5ug(0,1,6) | C:49 | C:13 | C: 4 | C: 13 | C: 32 | |||||
Sun 2007 [34] | NR | 1 | T1: HBIG 200 IU (7,8,9) | T1: HBIG 200 IU(0,0.5) + V 5 ug(0,1,6) | T1:77 | T1: 2 | NR | T1:1 | T1: 73 | T1:0 | T1: 54 |
T2:None | T2: HBIG 200 IU(0,0.5) + V 5 ug(0,1,6) | T2:76 | T2: 10 | T2: 4 | T2: 70 | T2:1 | T2: 50 | ||||
C: None | C : V 5ug(0,1,6) | C:70 | C: 9 | C: 8 | C: 58 | C: 4 | C: 30 | ||||
Wang 2007 [35] | NR | 1 | T: HBIG 200 IU (4–9) | T: HBIG 200 IU(0,0.5) + V 10 ug(1,2,7) | T:32 | T: 2 | NR | T: 2 | NR | NR | NR |
C: none | C: HBIG 200 IU(0,0.5) + V 10 ug(1,2,7) | C:31 | C: 11 | Â | C: 12 | ||||||
Yan 2009 [36] | 22-35 | 1 | T: HBIG 400 IU (7,8,9) | T: HBIG 200 IU(0,0.5) + RV 10 ug(0,1,6) | T:106 | T:10 | T:37 | T: 9 | T: 82 | T:8 | T: 93 |
C: none | C: RV 10ug(0,1,6) | C:98 | C:23 | C: 9 | C: 21 | C: 46 | C:20 | C: 69 | |||
Cui 2011 [37] | NR | 1 | T: HBIG 200 IU, 3 time | T: HBIG 100 IU, 2time + RV 5 ug, 0, 1,6 | T:106 | NR | NR | NR | NR | T:5 | T:96 |
C: none | C: RV 5 ug, 0, 1,6 | C:82 | C:16 | C:60 | |||||||
Zhu 1997 [38] | NR | 1 | T: HBIG 200 IU (7,8,9) | NR | T:37 | T: 6 | NR | NR | NR | NR | NR |
C:32 | C: 12 | ||||||||||
Repeated [39] | 2 | C: none | T:68 | T: 0 | NR | NR | NR | NR | NR | ||
C:70 | C: 3 | ||||||||||
Jia 2001 [40] | NR | 1 | T: HBIG 200 IU (7,8,9) | NR | T:15 | T: 1 | NR | NR | NR | NR | NR |
C:16 | C: 7 | ||||||||||
2 | C: none | T:25 | T: 0 | NR | NR | NR | NR | NR | |||
C:30 | C: 3 | ||||||||||
Chi 2002 [41] | NR | 1 | T: HBIG 200 IU (7,8,9) | NR | T:27 | T:4 | NR | NR | NR | NR | NR |
C:29 | C:10 | ||||||||||
2 | C: none | T:42 | T: 0 | NR | NR | NR | NR | NR | |||
C:43 | C:2 | ||||||||||
Chen2003 [42] | NR | 1 | T: HBIG 200 IU (7,8,9) | NR | T:18 | T:2 | NR | NR | NR | NR | NR |
C:15 | C:6 | ||||||||||
2 | C: none | T:26 | T: 1 | NR | NR | NR | NR | NR | |||
C:20 | C: 2 | ||||||||||
Han 2003 [43] | NR | 1 | T: HBIG 200 IU (7,8,9) | T: HBIG 200 IU(0,0.5) + V 5 ug(1,2,7) | T:83 | T:21 | NR | T: 5 | NR | NR | NR |
C:52 | C:23 | C: 7 | |||||||||
Repeated [44] | 2 | C: None | C : HBIG 200 IU(0,0.5) + V 5 ug(1,2,7) | T:43 | T: 3 | NR | T: 0 | NR | NR | NR | |
C:38 | C: 9 | Â | C: 5 | ||||||||
Xing 2003 [45] | 22-38 | 1 | T: HBIG 200 IU (7,8,9) | NR | T:16 | T: 2 | NR | NR | NR | NR | NR |
C:15 | C: 6 | ||||||||||
Repeated [46] | 2 | C: None | T:30 | T: 0 | NR | NR | NR | NR | NR | ||
C:25 | C: 3 | ||||||||||
Zhu 2003 [47] | NR | 1 | T: HBIG 200-400 IU (7,8,9) | T: HBIG 100 IU(0,0.5) + RV 5 ug(1,2,7) or PDV 30 ug(1,2,7) | T:169 | T:21 | NR | NR | NR | NR | NR |
C:189 | C:49 | ||||||||||
Repeated [48] | Â | 2 | C: none | C: HBIG 100 IU(0,0.5) + RV 5ug(1,2,7) or PDV 30 ug(1,2,7) | T:318 | T:7 | NR | NR | NR | NR | NR |
C:304 | C:22 | ||||||||||
Chen 2006 [49] | NR | 1 | T: HBIG 200 IU (7,8,9) | NR | T:16 | T: 4 | NR | NR | NR | NR | NR |
C:14 | C: 9 | ||||||||||
2 | C: none | T:34 | T: 1 | NR | NR | NR | NR | NR | |||
C:36 | C: 5 | ||||||||||
Yang 2006 [50] | NR | 1 | T: HBIG 200 IU (4–9) | NR | T:117 | T: 12 | T:7 | NR | NR | NR | NR |
C: None | Â | C:90 | C: 48 | C: 0 | |||||||
2 | T: HBIG 200 IU (7,8,9) | T:46 | T: 2 | T:10 | NR | NR | NR | NR | |||
C: None | C:32 | C:14 | C: 0 | ||||||||
Yu 2006 [51] | NR | 1 | T1: HBIG 200-400 IU (7–10) | NR | T1:8 | T1:3 | NR | NR | NR | NR | NR |
T2:7 | T2:5 | ||||||||||
C:8 | C: 8 | ||||||||||
2 | T2: HBIG 200 IU (7,8,9) | Â | T1:18 | T1:0 | NR | NR | NR | NR | NR | ||
T2:22 | T2:0 | ||||||||||
C:20 | C:2 | ||||||||||
C: Diluent | |||||||||||
Ji 2007 [52] | NR | 1 | T: HBIG 200 IU (7,8,9) | T: HBIG 200 IU(0) + RV 5 ug(0,1,6) | T:30 | T:2 | NR | T: 1 | NR | NR | NR |
C:26 | C:10 | C: 6 | |||||||||
2 | C: None | C: HBIG 200 IU(0,0.5) + RV 5 ug(0,1,6) | T:83 | T:3 | NR | T: 1 | NR | NR | NR | ||
C:84 | C:5 | C: 3 | |||||||||
Liu 2007 [53] | NR | 1 | T: HBIG 200 IU (7,8,9) | T: HBIG 200 IU(0,0.5) + RV 10 ug(0,1,6) | T:12 | T: 1 | T: 4 | T: 0 | T:10 | NR | NR |
C:9 | C: 2 | C: 1 | C: 2 | C: 4 | |||||||
2 | C: None | C: HBIG 200 IU(0,0.5) + RV 10 ug(0,1,6) | T:31 | T: 1 | T: 12 | T: 0 | T:24 | NR | NR | ||
C:34 | C: 1 | C: 12 | C: 1 | C:25 | |||||||
Wang 2008 [54] | 20-33 | 1 | T:HBIG 200 IU(5–9) | T: HBIG 200 IU(0,0.5) + V | T:79 | T:8 | NR | T: 7 | NR | NR | NR |
C:60 | C: 19 | C: 14 | |||||||||
2 | C: None | C:V | T:80 | T: 2 | NR | T: 0 | NR | NR | NR | ||
C:60 | C:8 | C: 5 | |||||||||
Zhao 2008 [55] | 20-34 | 1 | T: HBIG 200 IU (7,8,9) | NR | T:37 | T: 6 | NR | NR | NR | NR | NR |
C:32 | C:12 | ||||||||||
2 | C: none | T:66 | T: 0 | NR | NR | NR | NR | NR | |||
C:69 | C:3 | ||||||||||
Liu 2009 [58] | NR | 1 | T: HBIG 200 IU (7,8,9) | NR | NR | NR | NR | NR | NR | NR | NR |
2 | C: none | T:100 | T: 1 | NR | NR | NR | NR | NR | |||
C:120 | C:4 | ||||||||||
Yuan 2009 [57] | 20-40 | 1 | T1: HBIG 200 IU (7,8,9) | T1: HBIG 200 IU(0,0.5) + RV 5 ug(0,1,6) | T1:4 | NR | NR | T1: 0 | T1:13 | NR | NR |
T2:9 | T2: 3 | T2: 7 | |||||||||
T2: None | T2: HBIG 200 IU(0,0.5) + RV 5 ug(0,1,6) | C:13 | C: 5 | C: 10 | |||||||
2 | C: None | C: RV 5 ug(0,1,6) | T1:23 | NR | NR | T1:1 | T1:23 | NR | NR | ||
T2:13 | T2:2 | T2:12 | |||||||||
C:13 | C: 1 | C: 7 | |||||||||
Li 2013 [58] | 24-35 | 1 | T: HBIG 200 IU (7,8,9) | T: HBIG 100 IU, 6 h + RV 10 ug, 0, 1,6 | T:38 | T:2 | T:34 | T:0 | T:36 | NR | NR |
C:34 | C:12 | C:15 | C:11 | C:15 | |||||||
2 | C: none | C: HBIG 100 IU, 6 h + RV 10 ug, 0, 1,6 | T:14 | T:0 | T:13 | T:0 | T:14 | NR | NR | ||
C:28 | C:3 | C:20 | C:1 | C:25 |